• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Podcast » Lithium and Cognition: The Largest Study to Date [60 Second Psych]

The Carlat Psychiatry Podcast
The Carlat Psychiatry Podcast RSS FeedRSS

Clear, engaging, and practical updates on clinical psychiatry.
Earn CME for listening to the podcast with a Podcast CME Subscription.
Listen for free here or using Apple Podcasts and Spotify.

Lithium and Cognition: The Largest Study to Date [60 Second Psych]

August 12, 2020


This study is the largest longitudinal study of cognition in lithium to date. Katherine Burdick and colleagues started with 262 patients with bipolar I – 64% were taking lithium [Link]. They made two key measurements, with the main limitation that neither were controlled. Here's the findings.

Published On: 8/12/2020

Duration: 2 minutes, 49 seconds

Transcript:

Researchers and patients disagree on lithium. Patients often complain of cognitive dulling on it, but research find that lithium has more neuroprotective effects than other mood stabilizers. It prevents dementia and increases hippocampal and amygdale volume and cortical thickness


This study is the largest longitudinal study of cognition in lithium to date. Katherine Burdick and colleagues started with 262 patients with bipolar I–64% were taking lithium. They made two key measurements, with the main limitation that neither were controlled:


First, they found no difference at baseline in cognitive testing for patients taking or not taking lithium. The ones who were not on lithium had more severe manic and depressive symptoms at the time of testing. This suggests lithium’s cognitive effects are not much different from other meds.


Second, they did longitudinal testing on the patients who responded well to lithium–and half of the ones on lithium did have good sustained stability on it. When these patients were followed up about 4 months later, a third had improved cognition and there was no evidence of impaired cognition.


These encouraging results are in contrast to uncontrolled studies show mild impairments on measures of processing speed, verbal learning, and creativity with long term lithium use. Today’s study didn’t look at creativity.  In studies of healthy subjects lithium doesn’t seem to impair cognition. The researchers attributed part of the cognitive success they observed to the relatively low levels of lithium they used – around 0.6 – which is within the 0.6-0.8 range recommended for maintenance therapy.


I’m only aware of one controlled study of cognition on lithium – this was a 2016 trial by Michael Berk’s group that randomized patients to lithium or quetiapine for mania, and at follow up one year later the lithium patients had better verbal fluency.


The bottom line: Lithium likely has cognitive benefits, but patients may feel slowed down, dull, or uncreative on it. Stick to the lower dose range  0.6-0.8 for maintenance.


Got feedback? Take the podcast survey.
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2603816031.jpg
    General Psychiatry

    A Scam for Every Woman, Child, and Man: Part 2

    1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.